In a small study that sequenced the tumors of a few patients, it was intriguing that PTPRD germline aberrations conferred clinical benefit to patients with Ewing sarcoma who received therapy directed at the IGF1R and mTOR pathway [18]. The gene discussed is IGF1R; the disease is Ewing sarcoma.